Cargando…

Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders

BACKGROUND: Since RNA expression differences have been reported in autism spectrum disorder (ASD) for blood and brain, and differential alternative splicing (DAS) has been reported in ASD brains, we determined if there was DAS in blood mRNA of ASD subjects compared to typically developing (TD) contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Stamova, Boryana S, Tian, Yingfang, Nordahl, Christine W, Shen, Mark D, Rogers, Sally, Amaral, David G, Sharp, Frank R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846739/
https://www.ncbi.nlm.nih.gov/pubmed/24007566
http://dx.doi.org/10.1186/2040-2392-4-30
_version_ 1782293478908100608
author Stamova, Boryana S
Tian, Yingfang
Nordahl, Christine W
Shen, Mark D
Rogers, Sally
Amaral, David G
Sharp, Frank R
author_facet Stamova, Boryana S
Tian, Yingfang
Nordahl, Christine W
Shen, Mark D
Rogers, Sally
Amaral, David G
Sharp, Frank R
author_sort Stamova, Boryana S
collection PubMed
description BACKGROUND: Since RNA expression differences have been reported in autism spectrum disorder (ASD) for blood and brain, and differential alternative splicing (DAS) has been reported in ASD brains, we determined if there was DAS in blood mRNA of ASD subjects compared to typically developing (TD) controls, as well as in ASD subgroups related to cerebral volume. METHODS: RNA from blood was processed on whole genome exon arrays for 2-4–year-old ASD and TD boys. An ANCOVA with age and batch as covariates was used to predict DAS for ALL ASD (n=30), ASD with normal total cerebral volumes (NTCV), and ASD with large total cerebral volumes (LTCV) compared to TD controls (n=20). RESULTS: A total of 53 genes were predicted to have DAS for ALL ASD versus TD, 169 genes for ASD_NTCV versus TD, 1 gene for ASD_LTCV versus TD, and 27 genes for ASD_LTCV versus ASD_NTCV. These differences were significant at P <0.05 after false discovery rate corrections for multiple comparisons (FDR <5% false positives). A number of the genes predicted to have DAS in ASD are known to regulate DAS (SFPQ, SRPK1, SRSF11, SRSF2IP, FUS, LSM14A). In addition, a number of genes with predicted DAS are involved in pathways implicated in previous ASD studies, such as ROS monocyte/macrophage, Natural Killer Cell, mTOR, and NGF signaling. The only pathways significant after multiple comparison corrections (FDR <0.05) were the Nrf2-mediated reactive oxygen species (ROS) oxidative response (superoxide dismutase 2, catalase, peroxiredoxin 1, PIK3C3, DNAJC17, microsomal glutathione S-transferase 3) and superoxide radical degradation (SOD2, CAT). CONCLUSIONS: These data support differences in alternative splicing of mRNA in blood of ASD subjects compared to TD controls that differ related to head size. The findings are preliminary, need to be replicated in independent cohorts, and predicted alternative splicing differences need to be confirmed using direct analytical methods.
format Online
Article
Text
id pubmed-3846739
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38467392013-12-06 Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders Stamova, Boryana S Tian, Yingfang Nordahl, Christine W Shen, Mark D Rogers, Sally Amaral, David G Sharp, Frank R Mol Autism Research BACKGROUND: Since RNA expression differences have been reported in autism spectrum disorder (ASD) for blood and brain, and differential alternative splicing (DAS) has been reported in ASD brains, we determined if there was DAS in blood mRNA of ASD subjects compared to typically developing (TD) controls, as well as in ASD subgroups related to cerebral volume. METHODS: RNA from blood was processed on whole genome exon arrays for 2-4–year-old ASD and TD boys. An ANCOVA with age and batch as covariates was used to predict DAS for ALL ASD (n=30), ASD with normal total cerebral volumes (NTCV), and ASD with large total cerebral volumes (LTCV) compared to TD controls (n=20). RESULTS: A total of 53 genes were predicted to have DAS for ALL ASD versus TD, 169 genes for ASD_NTCV versus TD, 1 gene for ASD_LTCV versus TD, and 27 genes for ASD_LTCV versus ASD_NTCV. These differences were significant at P <0.05 after false discovery rate corrections for multiple comparisons (FDR <5% false positives). A number of the genes predicted to have DAS in ASD are known to regulate DAS (SFPQ, SRPK1, SRSF11, SRSF2IP, FUS, LSM14A). In addition, a number of genes with predicted DAS are involved in pathways implicated in previous ASD studies, such as ROS monocyte/macrophage, Natural Killer Cell, mTOR, and NGF signaling. The only pathways significant after multiple comparison corrections (FDR <0.05) were the Nrf2-mediated reactive oxygen species (ROS) oxidative response (superoxide dismutase 2, catalase, peroxiredoxin 1, PIK3C3, DNAJC17, microsomal glutathione S-transferase 3) and superoxide radical degradation (SOD2, CAT). CONCLUSIONS: These data support differences in alternative splicing of mRNA in blood of ASD subjects compared to TD controls that differ related to head size. The findings are preliminary, need to be replicated in independent cohorts, and predicted alternative splicing differences need to be confirmed using direct analytical methods. BioMed Central 2013-09-04 /pmc/articles/PMC3846739/ /pubmed/24007566 http://dx.doi.org/10.1186/2040-2392-4-30 Text en Copyright © 2013 Stamova et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Stamova, Boryana S
Tian, Yingfang
Nordahl, Christine W
Shen, Mark D
Rogers, Sally
Amaral, David G
Sharp, Frank R
Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
title Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
title_full Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
title_fullStr Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
title_full_unstemmed Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
title_short Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
title_sort evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846739/
https://www.ncbi.nlm.nih.gov/pubmed/24007566
http://dx.doi.org/10.1186/2040-2392-4-30
work_keys_str_mv AT stamovaboryanas evidencefordifferentialalternativesplicinginbloodofyoungboyswithautismspectrumdisorders
AT tianyingfang evidencefordifferentialalternativesplicinginbloodofyoungboyswithautismspectrumdisorders
AT nordahlchristinew evidencefordifferentialalternativesplicinginbloodofyoungboyswithautismspectrumdisorders
AT shenmarkd evidencefordifferentialalternativesplicinginbloodofyoungboyswithautismspectrumdisorders
AT rogerssally evidencefordifferentialalternativesplicinginbloodofyoungboyswithautismspectrumdisorders
AT amaraldavidg evidencefordifferentialalternativesplicinginbloodofyoungboyswithautismspectrumdisorders
AT sharpfrankr evidencefordifferentialalternativesplicinginbloodofyoungboyswithautismspectrumdisorders